 |
2 Diseases |  |
0 Trials |
|
0 Trials |  |
10 News |  |
- mibenratide (COR1) / J&J
Enrollment change, Trial withdrawal: A Crossover Study to Evaluate the Effect of JNJ-54452840 on Pharmacodynamics of Metoprolol Tartrate Immediate-Release in Healthy Participants (clinicaltrials.gov) - Nov 1, 2016
P1, N=0, Withdrawn, Sponsor: Janssen Research & Development, LLC
N=12 --> 0 | Not yet recruiting --> Withdrawn
- | mibenratide (COR1) / J&J
Trial completion: To Assess the Pharmacokinetics and Safety of Single Doses of JNJ-54452840 in Healthy Japanese and Caucasian Participants (clinicaltrials.gov) - Jan 5, 2015
P1, N=32, Completed, Sponsor: Janssen Research & Development, LLC
N=12 --> 0 | Not yet recruiting --> Withdrawn Active, not recruiting --> Completed
- mibenratide (COR1) / J&J
Trial withdrawal: A Study to Assess the Pharmacokinetics and Pharmacodynamics of JNJ-54452840 in Participants With Heart Failure and Anti-beta1-adrenergic Receptor Autoantibodies (clinicaltrials.gov) - Apr 7, 2014
P2, N=0, Withdrawn, Sponsor: Janssen Research & Development, LLC
Active, not recruiting --> Completed Not yet recruiting --> Withdrawn
- mibenratide (COR1) / J&J
Trial initiation date: A Study to Assess the Pharmacokinetics and Pharmacodynamics of JNJ-54452840 in Participants With Heart Failure and Anti-beta1-adrenergic Receptor Autoantibodies (clinicaltrials.gov) - Apr 7, 2014
P2, N=0, Withdrawn, Sponsor: Janssen Research & Development, LLC
Not yet recruiting --> Withdrawn Initiation date: Dec 2013 --> Nov 2014
- mibenratide (COR1) / J&J
Enrollment change: A Study to Assess the Pharmacokinetics and Pharmacodynamics of JNJ-54452840 in Participants With Heart Failure and Anti-beta1-adrenergic Receptor Autoantibodies (clinicaltrials.gov) - Apr 7, 2014
P2, N=0, Withdrawn, Sponsor: Janssen Research & Development, LLC
Initiation date: Dec 2013 --> Nov 2014 N=110 --> 0
- mibenratide (COR1) / J&J
Enrollment closed: To Assess the Pharmacokinetics and Safety of Single Doses of JNJ-54452840 in Healthy Japanese and Caucasian Participants (clinicaltrials.gov) - Dec 1, 2013
P1, N=32, Active, not recruiting, Sponsor: Janssen Research & Development, LLC
N=110 --> 0 Not yet recruiting --> Active, not recruiting
- | mibenratide (COR1) / J&J
New P1 trial: A Crossover Study to Evaluate the Effect of JNJ-54452840 on Pharmacodynamics of Metoprolol Tartrate Immediate-Release in Healthy Participants (clinicaltrials.gov) - Jul 16, 2013
P1, N=12, Not yet recruiting, Sponsor: Janssen Research & Development, LLC
- | mibenratide (COR1) / J&J
New P1 trial: To Assess the Pharmacokinetics and Safety of Single Doses of JNJ-54452840 in Healthy Japanese and Caucasian Participants (clinicaltrials.gov) - Mar 10, 2013
P1, N=32, Active, not recruiting, Sponsor: Janssen Research & Development, LLC
- mibenratide (COR1) / J&J
New P2 trial: A Study to Assess the Pharmacokinetics and Pharmacodynamics of JNJ-54452840 in Participants With Heart Failure and Anti-beta1-adrenergic Receptor Autoantibodies (clinicaltrials.gov) - Feb 24, 2013
P2, N=0, Withdrawn, Sponsor: Janssen Research & Development, LLC